144 related articles for article (PubMed ID: 35571788)
1. SEMA6D Differentially Regulates Proliferation, Migration, and Invasion of Breast Cell Lines.
Gunyuz ZE; Sahi-Ilhan E; Kucukkose C; Ipekgil D; Tok G; Mese G; Ozcivici E; Yalcin-Ozuysal O
ACS Omega; 2022 May; 7(18):15769-15778. PubMed ID: 35571788
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin 6D as an independent predictor for better prognosis in clear cell renal cell carcinoma.
Duan J; Jin M; Qiao B
Transl Oncol; 2022 Aug; 22():101453. PubMed ID: 35605459
[TBL] [Abstract][Full Text] [Related]
3. MiR-195 and Its Target SEMA6D Regulate Chemoresponse in Breast Cancer.
Baxter DE; Allinson LM; Al Amri WS; Poulter JA; Pramanik A; Thorne JL; Verghese ET; Hughes TA
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885090
[TBL] [Abstract][Full Text] [Related]
4. Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.
He Q; Gong Y; Gower L; Yang X; Friesel RE
J Cell Biochem; 2016 Oct; 117(10):2346-56. PubMed ID: 26950413
[TBL] [Abstract][Full Text] [Related]
5. SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma.
Chen D; Li Y; Wang L; Jiao K
Int J Breast Cancer; 2015; 2015():539721. PubMed ID: 25973277
[TBL] [Abstract][Full Text] [Related]
6. The role of semaphorin 4D in tumor development and angiogenesis in human breast cancer.
Jiang H; Chen C; Sun Q; Wu J; Qiu L; Gao C; Liu W; Yang J; Jun N; Dong J
Onco Targets Ther; 2016; 9():5737-5750. PubMed ID: 27729799
[TBL] [Abstract][Full Text] [Related]
7. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
8. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
9. Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer.
Hirai T; Naito Y; Koyama S; Nakanishi Y; Masuhiro K; Izumi M; Kuge T; Naito M; Mizuno Y; Yamaguchi Y; Kang S; Yaga M; Futami Y; Nojima S; Nishide M; Morita T; Kato Y; Tsuda T; Takemoto N; Kinugasa-Katayama Y; Aoshi T; Villa JK; Yamashita K; Enokida T; Hoshi Y; Matsuura K; Tahara M; Takamatsu H; Takeda Y; Inohara H; Kumanogoh A
JCI Insight; 2024 Feb; 9(3):. PubMed ID: 38329122
[TBL] [Abstract][Full Text] [Related]
10. [Semaphorin 6D and Snail are highly expressed in gastric cancer and positively correlated with malignant clinicopathological indexes].
Qu S; Yang Z; Tao H; Ji F; Chen P; Liang J; Lu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):932-937. PubMed ID: 31814570
[TBL] [Abstract][Full Text] [Related]
11. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
Juang YL; Jeng YM; Chen CL; Lien HC
Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells.
Jang JY; Kim MK; Jeon YK; Joung YK; Park KD; Kim CW
Exp Mol Med; 2012 Apr; 44(4):251-9. PubMed ID: 22198296
[TBL] [Abstract][Full Text] [Related]
13. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
14. TRPC6 Channels Are Required for Proliferation, Migration and Invasion of Breast Cancer Cell Lines by Modulation of Orai1 and Orai3 Surface Exposure.
Jardin I; Diez-Bello R; Lopez JJ; Redondo PC; Salido GM; Smani T; Rosado JA
Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30223530
[TBL] [Abstract][Full Text] [Related]
15. Pro-metastatic functions of Notch signaling is mediated by CYR61 in breast cells.
Ilhan M; Kucukkose C; Efe E; Gunyuz ZE; Firatligil B; Dogan H; Ozuysal M; Yalcin-Ozuysal O
Eur J Cell Biol; 2020 Apr; 99(2-3):151070. PubMed ID: 32005345
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of RhoGDIα increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells.
Hooshmand S; Ghaderi A; Yusoff K; Karrupiah T; Rosli R; Mojtahedi Z
Cell Adh Migr; 2013; 7(3):297-303. PubMed ID: 23563506
[TBL] [Abstract][Full Text] [Related]
17. Connexin 32 induces pro-tumorigenic features in MCF10A normal breast cells and MDA-MB-231 metastatic breast cancer cells.
Adak A; Unal YC; Yucel S; Vural Z; Turan FB; Yalcin-Ozuysal O; Ozcivici E; Mese G
Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118851. PubMed ID: 32918981
[TBL] [Abstract][Full Text] [Related]
18. Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis.
Lu Y; Xu Q; Chen L; Zuo Y; Liu S; Hu Y; Li X; Li Y; Zhao X
Oncol Lett; 2016 Nov; 12(5):3967-3974. PubMed ID: 27895757
[TBL] [Abstract][Full Text] [Related]
19. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
